Expression of pro-inflammatory cytokines (IL-6 & IL-18) exacerbate the risk of diabetic nephropathy in the Pakistani population

[1]  S. Akhtar,et al.  Increased Expression of Circulating Stress Markers, Inflammatory Cytokines and Decreased Antioxidant Level in Diabetic Nephropathy , 2022, Medicina.

[2]  M. Nasr-Esfahani,et al.  The NLRP3 inflammasome: molecular activation and regulation in spermatogenesis and male infertility; a systematic review , 2022, Basic and Clinical Andrology.

[3]  Yonas Akalu,et al.  Association of IL-10 (− 1082 A/G) and IL-6 (− 174 G/C) gene polymorphism with type 2 diabetes mellitus in Ethiopia population , 2021, BMC Endocrine Disorders.

[4]  J. Navarro-González,et al.  Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications , 2021, Frontiers in Medicine.

[5]  B. Satirapoj,et al.  Impaired Glomerular Filtration Rate in Type 2 Diabetes Mellitus Subjects: A Nationwide Cross-Sectional Study in Thailand , 2020, Journal of diabetes research.

[6]  Chao Liu,et al.  Research Progress on the Role of Inflammasomes in Kidney Disease , 2020, Mediators of inflammation.

[7]  Jieqiong Lou,et al.  Risk factors for diabetic nephropathy complications in community patients with type 2 diabetes mellitus in Shanghai: Logistic regression and classification tree model analysis. , 2019, The International journal of health planning and management.

[8]  M. Shirakawa,et al.  An innate interaction between IL-18 and the propeptide that inactivates its precursor form , 2019, Scientific Reports.

[9]  N. Hadi,et al.  Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy. , 2019, Diabetes & metabolic syndrome.

[10]  S. Atkin,et al.  Interleukin‐18 and diabetic nephropathy: A review , 2018, Journal of cellular physiology.

[11]  S. Dinneen,et al.  What is diabetes? , 2006, Medicine.

[12]  N. Moradi,et al.  Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-α and IL-6. , 2019, Cytokine.

[13]  Vahideh Hassan-Zadeh,et al.  Hyperglycemia Affects the Expression of Inflammatory Genes in Peripheral Blood Mononuclear Cells of Patients with Type 2 Diabetes , 2018, Immunological investigations.

[14]  A. Sahebkar,et al.  Oxidative stress induces renal failure: A review of possible molecular pathways , 2018, Journal of cellular biochemistry.

[15]  Z. Bashir,et al.  Interleukin-18 polymorphism as an inflammatory index in metabolic syndrome: A preliminary study , 2017, World journal of diabetes.

[16]  Chun Zhang,et al.  Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update , 2017, Front. Immunol..

[17]  Y. Qing,et al.  Associations Between Hyperuricemia and Chronic Kidney Disease: A Review , 2015, Nephro-urology monthly.

[18]  J. Navarro-González,et al.  Inflammatory Cytokines in Diabetic Nephropathy , 2015, Journal of diabetes research.

[19]  N. Agrawal,et al.  Targeting inflammation in diabetes: Newer therapeutic options. , 2014, World journal of diabetes.

[20]  A. Rubio-Guerra,et al.  Diabetic nephropathy and inflammation. , 2014, World journal of diabetes.

[21]  Y. Zha,et al.  Urine interleukin-18 in prediction of acute kidney injury: a systemic review and meta-analysis , 2014, Journal of Nephrology.

[22]  K. Al-Rubeaan,et al.  Diabetic Nephropathy and Its Risk Factors in a Society with a Type 2 Diabetes Epidemic: A Saudi National Diabetes Registry-Based Study , 2014, PloS one.

[23]  D. Maixnerova,et al.  The coincidence of IgA nephropathy and Fabry disease , 2013, BMC Nephrology.

[24]  G. Tesch,et al.  Inflammation in Diabetic Nephropathy , 2012, Mediators of inflammation.

[25]  S. Barra,et al.  Glomerular filtration rate, Which formula should be used in patients with myocardial infarction? , 2012 .

[26]  D. Maahs,et al.  Uric acid as a mediator of diabetic nephropathy. , 2011, Seminars in nephrology.

[27]  Koichi Matsumoto,et al.  Serum interleukin-18 binding protein increases with behavior different from IL-18 in patients with diabetic nephropathy. , 2011, Diabetes Research and Clinical Practice.

[28]  M. Ares,et al.  Purification of RNA using TRIzol (TRI reagent). , 2010, Cold Spring Harbor protocols.

[29]  R. Khalil,et al.  Inflammatory cytokines in vascular dysfunction and vascular disease. , 2009, Biochemical pharmacology.

[30]  M. Netea,et al.  Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus , 2008, International Journal of Obesity.

[31]  R. Bank,et al.  Differentiation of adipose stem cells by nucleus pulposus cells: configuration effect. , 2007, Biochemical and biophysical research communications.